# TG Therapeutics, Inc.: Form 8-K, filed Jun 15, 2023

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2023-06-15
- Accepted by EDGAR: Jun 15, 2023, 16:30 ET
- Period: 2023-06-14
- Accession: 0001558370-23-011140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/tgtx-20230614x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/tgtx-20230614x8k.htm

Filed Jun 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-011140. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.